Some of the stocks that may grab investor focus today are:
- Moderna Inc MRNA confirmed talks with the government of South Korea to supply the nation with 40 million doses of Covid-19 vaccine. The company also said that its vaccine will be made available to its workers, contractors, and board members under the FDA emergency use authorization. Moderna shares gained 2.7% to close at $114.39 on Tuesday, while declining 0.1% in after-hours trading.
- China Finance Online Co. JRJC reported a Q3 loss of $0.66 per share, versus a year-ago loss of $0.91 per share. Its net revenue climbed to $10.7 million from $8.1 million. China Finance Online shares dipped 25.4% to $8.20 in the after-hours trading session.
- AstraZeneca plc AZN disclosed that its COVID-19 vaccine has received approval in the United Kingdom for emergency use. AstraZeneca shares gained 2.2% to $51.00 in after-hours trading.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Choosing the best broker is an important part of being a successful trader or investor
- Shares of Hepion Pharmaceuticals Inc HEPA jumped around 25% on Tuesday after the company disclosed "positive" top line data from the low dose cohort in its Phase 2a 'AMBITION' clinical trial of CRV431. Hepion Pharmaceuticals shares surged 24.5% to $2.59 in after-hours trading.
- Microvision, Inc. MVIS reported a $13 million at-the-market equity facility. Microvision shares dipped 6.7% to $5.90 in the after-hours trading session.
AZNAstraZeneca PLC
$69.730.26%
Edge Rankings
Momentum
38.15
Growth
97.38
Quality
48.57
Value
19.59
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in